The program covers updates on collaborative initiatives and implementation of precision cancer medicine across the Nordics as well as in other European countries and beyond.
Program details will be available soon. Already confirmed speakers are listed under "Speakers".
September 17-19, 2023
Oslo, Norway
September 17
Get together
September 18
Keynote Speaker David Thomas, Garvan Institute of Medical Research, Australia
Omico: Australia's Genomic Cancer Medicine Centre
Funda Meric-Bernstam, MD Anderson Cancer Centre, USA
Short Abstract Talk TBC (10 + 5 min)
Maud Kamal, Institut Curie, Paris
Short Abstract Talk TBC (10 + 5 min)
Lynette Sholl, Dana-Farber / Harvard Cancer Center, USA
Lunch
Poster Session
Christophe Le Tourneau, Institut Curie, Paris
Short Abstract Talk TBC (10 + 5 min)
Emile Voest, NCI, The Netherlands
Short Abstract Talk TBC (10 + 5 min)
Richard Schilsky, University of Chicago, USA
Aperitif in the reception area
Dinner
September 19
Keynote Speaker Gordon Mills, Knight Cancer Institute, OHSU, USA:
Targeting adaptive responses in cancer through SMMART clinical trials
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, CZ Health Insurance, The Netherlands
Short Abstract Talk TBC (10 + 5 min)
Bettina Ryll, Stockholm School of Economics, Sweden
Short Abstract Talk TBC (10 + 5 min)
Monika Frenzel, French National Research Agency
Lunch
Jesus Garcia-Foncillas, Jiménez Diaz Foundation University Hospital, Madrid, Spain
Short Abstract Talk TBC (10 + 5 min)
Benedikt Westphalen, LMU Munich, Germany
Short Abstract Talk TBC (10 + 5 min)
Christopher McCabe, Queen's University Belfast, Northern Ireland, UK
Coffee Break
Hans Gelderblom, Leiden University Medical Centre, The Netherlands
Åslaug Helland, Oslo University Hospital, Oslo, Norway
Ulrik Lassen, Rigshospitalet, Copenhagen, Denmark
Katriina Peltola, Helsinki University Hospital, Finland
Loic Verlingue, Centre Léon Bérard, Lyon, France
Matthew Krebs, University of Manchester, UK
Maeve Lowery, Trinity College Dublin and St James Hospital, Ireland
Concluding Remarks
An Acta Oncologica Conference
The overarching theme of this two-day conference is precision cancer medicine. Internationally renowned speakers will give scientific updates as well as updates on collaborative initiatives and implementation of precision cancer medicine across the Nordics and other European countries. Furthermore, patient benefit and visions for the future, including standard health care, is on the agenda.
An Acta Oncologica Conference
